Matinas BioPharma | Investor Presentation Deck | 29 slides

Matinas BioPharma · 2024-02
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

29
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
present_solution
Open slide detailLoop · Golden Circle
04
The slide uses a combination of molecular diagrams and bulleted lists to explain the mechanism and benefits of the LNC technology.present_solution
05
The slide uses a biological mechanism of action (MOA) framework to describe how LNCs (lipid nanocochleates) utilize PS to target cells.present_solution
06
transition
07
The slide uses a 'media montage' approach to establish urgency and external validation of the problem.frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
08
Uses a 'Before-After-Bridge' style logic to frame the drug's value proposition.present_solution
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
09
The slide uses a process-flow diagram to present five key clinical outcomes.summarize
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
10
The slide displays the header and author list of a published medical journal article.cite_precedent
Open slide detailLoop · Cost Of Inaction
11
The slide uses a human silhouette as a central anchor to map specific fungal pathogens to their corresponding infection sites in the body.illustrate_case
Open slide detailLoop · Cost Of Inaction
12
summarize
Open slide detailLoop · Cost Of Inaction
13
Includes a timeline diagram and two line charts tracking Creatinine and Potassium levels over time.illustrate_case
Open slide detailLoop · Cost Of Inaction
14
frame_problem
Open slide detailLoop · Cost Of Inaction
15
plan_implementation
Open slide detailBeat · Solution & Approach
16
The slide uses a timeline-based process flow to illustrate the clinical trial structure.present_framework
17
The slide uses a simple additive equation to define the product's core benefit, followed by a chevron-based timeline for life cycle management.present_solution
18
transition
19
The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical trial indications.illustrate_case
20
Uses a chevron-based process flow to represent maturity stages: Proven, Under Evaluation, and Future.plan_implementation
21
The chart shows dose-response curves where LNC formulations consistently outperform Taxol.analyze_data
22
The study design is a timeline showing tumor cell injection, treatment initiation, and sacrifice. The chart shows tumor volume over time for four treatment grouillustrate_case
23
Data from a human ex-vivo whole blood study.analyze_data
24
Includes longitudinal line charts and bar charts for Day 7 endpoints across 5 treatment groups.analyze_data
25
Includes study design details (6 groups, n=55, C57BL/6 mice) and statistical significance markers.analyze_data
26
summarize
27
summarize
28
The slide uses a two-column layout to separate the executive team (with headshots and logos) from the board of directors (with names, titles, and associated comother
29
The slide uses a split-layout: left side for financial summary, right side for milestones and value proposition.present_solution